NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika Virus

Go back to NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika Virus
NEWLINK GENETICS (NASDAQ: NLNK) Delayed: 0.89 --0 (-0%)
Previous Close $0.89    52 Week High $38.92 
Open $5.96    52 Week Low $9.23 
Day High $0.89    P/E N/A 
Day Low $0.89    EPS $-1.23 
Volume 77